Sir Chris Evans on EDX Medical’s partnership to develop rapid pneumonia test (AQSE:EDX) 13 August 2025
Union Jack Oil Accelerates Growth with UK Production Boost and US Exploration Upside, Zeus Capital 10 July 2025
Victorian Plumbing Group “in stronger position with extra capacity” says fund manager (LON:VIC) 10 October 2025
CMC Markets plc software stack, scale-up potential and cash generation excites Gervais Williams (LON:CMCX) 10 October 2025
Fund manager interview on Diversified Energy – US gas, fantastic yield and growing US base (LON:DEC) 10 October 2025
AstraZeneca’s Tezspire recommended for EU approval in chronic rhinosinusitis with nasal polyps 22 September 2025
WETHERSPOON (JDW.L) Stock Analysis: Exploring a Potential 18% Upside Despite Current Challenges 10 October 2025
Vistry Group PLC (VTY.L): Investor Outlook Amidst Narrow Potential Upside and Contrasting Analyst Ratings 10 October 2025
Trustpilot Group (TRST.L) Stock Analysis: Exploring a Potential 51% Upside in the Tech Sector 10 October 2025
VinaCapital Vietnam Opportunity Fund (VOF.L) Stock Analysis: Unearthing the Potential Amid Limited Analyst Coverage 10 October 2025
Workspace Group PLC (WKP.L): Investor Outlook on Growth Potential Amid Elevated Dividend Yield 10 October 2025
Sir Chris Evans on EDX Medical’s partnership to develop rapid pneumonia test (AQSE:EDX) 13 August 2025
Union Jack Oil Accelerates Growth with UK Production Boost and US Exploration Upside, Zeus Capital 10 July 2025
Victorian Plumbing Group “in stronger position with extra capacity” says fund manager (LON:VIC) 10 October 2025
CMC Markets plc software stack, scale-up potential and cash generation excites Gervais Williams (LON:CMCX) 10 October 2025
Fund manager interview on Diversified Energy – US gas, fantastic yield and growing US base (LON:DEC) 10 October 2025
AstraZeneca’s Tezspire recommended for EU approval in chronic rhinosinusitis with nasal polyps 22 September 2025
WETHERSPOON (JDW.L) Stock Analysis: Exploring a Potential 18% Upside Despite Current Challenges 10 October 2025
Vistry Group PLC (VTY.L): Investor Outlook Amidst Narrow Potential Upside and Contrasting Analyst Ratings 10 October 2025
Trustpilot Group (TRST.L) Stock Analysis: Exploring a Potential 51% Upside in the Tech Sector 10 October 2025
VinaCapital Vietnam Opportunity Fund (VOF.L) Stock Analysis: Unearthing the Potential Amid Limited Analyst Coverage 10 October 2025
Workspace Group PLC (WKP.L): Investor Outlook on Growth Potential Amid Elevated Dividend Yield 10 October 2025
Denali Therapeutics Inc. (DNLI) Stock Analysis: A Promising 106% Upside Potential in Biotechnology 2 September 2025
Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 39% Upside Potential in the Healthcare Sector 2 September 2025
Galapagos NV (GLPG) Stock Analysis: Evaluating the 19% Downside Potential Amid Biotech Challenges 2 September 2025
ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 38% Potential Upside with a Strong Buy Consensus 2 September 2025
ImmunityBio, Inc. (IBRX) Investor Outlook: Biotech Stock with a 335.90% Upside Potential 2 September 2025
AtriCure, Inc. (ATRC) Stock Analysis: Unpacking the 35% Upside Potential with Strong Buy Ratings 2 September 2025
ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: A Promising 15.23% Upside in the Biotech Sector 2 September 2025
UFP Technologies, Inc. (UFPT) Stock Analysis: 56.79% Potential Upside in the Booming Medical Devices Sector 2 September 2025
Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring a 29.74% Potential Upside in Biotech Innovation 2 September 2025
Belite Bio, Inc (BLTE) Stock Analysis: Exploring a 48.74% Potential Upside in Biotech 2 September 2025
GeneDx Holdings Corp. (WGS) Stock Analysis: Riding High on a 52-Week Peak with Cautious Optimism 2 September 2025
Ligand Pharmaceuticals (LGND) Investor Outlook: Analyzing a 7.21% Potential Upside in the Biotech Sector 2 September 2025
Ardent Health, Inc. (ARDT) Investor Outlook: Potential 51.87% Upside with Strong Buy Ratings 2 September 2025
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Strong Buy Ratings and Growth Potential in Rare Disease Market 2 September 2025
LivaNova PLC (LIVN) Stock Analysis: Exploring a 15% Potential Upside in the Medical Device Sector 2 September 2025
Concentra Group Holdings (CON) Stock Analysis: A Healthcare Powerhouse with 18.17% Upside Potential 2 September 2025
Envista Holdings Corporation (NVST): Investor Outlook Highlights Modest Upside Potential Amid Strong Analyst Interest 2 September 2025
Amedisys Inc (AMED) Investor Outlook: Navigating Growth in the Healthcare Sector with Robust Free Cash Flow 2 September 2025
LifeStance Health Group, Inc. (LFST) Stock Analysis: Uncovering a 53% Upside Potential in the Healthcare Sector 2 September 2025
Ilika plc £1.25M Grant Powers Goliath Battery Leap in UK’s EV Race, Graeme Purdy Explains (Video) 16 July 2025
Genuit acquires Davidson Holdings for £49m to expand plumbing and heating portfolio 29 September 2025
Sir Chris Evans on EDX Medical’s partnership to develop rapid pneumonia test (AQSE:EDX) 13 August 2025
Union Jack Oil Accelerates Growth with UK Production Boost and US Exploration Upside, Zeus Capital 10 July 2025
Victorian Plumbing Group “in stronger position with extra capacity” says fund manager (LON:VIC) 10 October 2025
CMC Markets plc software stack, scale-up potential and cash generation excites Gervais Williams (LON:CMCX) 10 October 2025
Fund manager interview on Diversified Energy – US gas, fantastic yield and growing US base (LON:DEC) 10 October 2025
WETHERSPOON (JDW.L) Stock Analysis: Exploring a Potential 18% Upside Despite Current Challenges 10 October 2025
Vistry Group PLC (VTY.L): Investor Outlook Amidst Narrow Potential Upside and Contrasting Analyst Ratings 10 October 2025
Trustpilot Group (TRST.L) Stock Analysis: Exploring a Potential 51% Upside in the Tech Sector 10 October 2025
VinaCapital Vietnam Opportunity Fund (VOF.L) Stock Analysis: Unearthing the Potential Amid Limited Analyst Coverage 10 October 2025
Workspace Group PLC (WKP.L): Investor Outlook on Growth Potential Amid Elevated Dividend Yield 10 October 2025
